NYSE American - Delayed Quote USD

Impact BioMedical Inc. (IBO)

Compare
1.7690
+0.1990
+(12.68%)
At close: January 24 at 3:59:53 PM EST
1.7000
-0.07
(-3.90%)
After hours: January 24 at 6:56:32 PM EST
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
Total Revenue
--
--
50.0000
50.0000
Operating Expense
3,661.0000
4,028.0000
3,454.0000
3,454.0000
Operating Income
-3,661.0000
-4,028.0000
-3,404.0000
-3,404.0000
Net Non Operating Interest Income Expense
-907.0000
-431.0000
-438.0000
-438.0000
Other Income Expense
5,670.0000
52.0000
-4,034.0000
-4,034.0000
Pretax Income
1,102.0000
-4,407.0000
-7,876.0000
-7,876.0000
Tax Provision
--
--
-621.0000
-621.0000
Net Income Common Stockholders
1,165.0000
-4,336.0000
-7,051.0000
-7,051.0000
Diluted NI Available to Com Stockholders
1,165.0000
-4,336.0000
-7,051.0000
-7,051.0000
Basic EPS
0.10
-0.38
-0.61
-0.61
Diluted EPS
0.10
-0.38
-0.61
-0.61
Basic Average Shares
11,503.9550
11,497.7030
11,497.7030
11,497.7030
Diluted Average Shares
11,503.9550
11,497.7030
11,497.7030
11,497.7030
Total Operating Income as Reported
-3,661.0000
-4,028.0000
-3,404.0000
-3,404.0000
Total Expenses
3,661.0000
4,028.0000
3,454.0000
3,454.0000
Net Income from Continuing & Discontinued Operation
1,165.0000
-4,336.0000
-7,051.0000
-7,051.0000
Normalized Income
-4,505.0000
-4,336.0000
-3,274.9000
-3,274.9000
Interest Income
13.0000
13.0000
24.0000
24.0000
Interest Expense
920.0000
444.0000
462.0000
462.0000
Net Interest Income
-907.0000
-431.0000
-438.0000
-438.0000
EBIT
2,022.0000
-3,963.0000
-7,414.0000
-7,414.0000
EBITDA
3,142.0000
-2,843.0000
-6,301.0000
-6,301.0000
Reconciled Depreciation
1,120.0000
1,120.0000
1,113.0000
1,113.0000
Net Income from Continuing Operation Net Minority Interest
1,165.0000
-4,336.0000
-7,051.0000
-7,051.0000
Total Unusual Items Excluding Goodwill
5,670.0000
--
-4,100.0000
-4,100.0000
Total Unusual Items
5,670.0000
--
-4,100.0000
-4,100.0000
Normalized EBITDA
-2,528.0000
-2,843.0000
-2,201.0000
-2,201.0000
Tax Rate for Calcs
--
--
0.0001
0.0001
Tax Effect of Unusual Items
--
--
-323.9000
-323.9000
12/31/2021 - 9/16/2024

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ESLA Estrella Immunopharma, Inc.
1.1300
0.00%
 
IBOGF Universal Ibogaine Inc.
0.0189
-17.11%
 
KLTO Klotho Neurosciences, Inc.
0.4201
-4.44%
 
IPSC Century Therapeutics, Inc.
0.9000
-1.11%
 
GLTO Galecto, Inc.
5.62
+3.09%
 
BRNS Barinthus Biotherapeutics plc
1.0100
-10.62%
 
KTTA Pasithea Therapeutics Corp.
2.4400
-2.40%
 
VBIZF Viva Biotech Holdings
0.0950
0.00%
 
IZTC Invizyne Technologies, Inc.
13.45
+13.12%
 
THAR Tharimmune, Inc.
2.0700
-7.17%